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Although there are seven mammalian sirtuins (SIRT1-7), little is known about their
expression in the aging brain. To characterize the change(s) in mRNA and protein
expression of SIRT1-7 and their associated proteins in the brain of “physiologically”
aged Wistar rats. We tested mRNA and protein expression levels of rat SIRT1-7, and the
levels of associated proteins in the brain using RT-PCR and western blotting. Our data
shows that SIRT1 expression increases with age, concurrently with increased acetylated
p53 levels in all brain regions investigated. SIRT2 and FOXO3a protein levels increased
only in the occipital lobe. SIRT3-5 expression declined significantly in the hippocampus
and frontal lobe, associated with increases in superoxide and fatty acid oxidation levels,
and acetylated CPS-1 protein expression, and a reduction in MnSOD level. While
SIRT6 expression declines significantly with age acetylated H3K9 protein expression
is increased throughout the brain. SIRT7 and Pol I protein expression increased in the
frontal lobe. This study identifies previously unknown roles for sirtuins in regulating cellular
homeostasis and healthy aging.
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Introduction
Sirtuins or “silent information regulators” of gene transcription, are a family of enzymes which are
expressed throughout all phyla of life. Accumulating evidence suggests that this unique class of
histone deacetylases are key regulators of numerous physiological processes, particularly in aging
in multiple organisms (Porcu and Chiarugi, 2005; Berdichevsky and Guarente, 2006; Longo and
Kennedy, 2006; Smith and Denu, 2006; Pallas et al., 2008; Schwer and Verdin, 2008). Gene silencing
by this family of enzymes has been correlated directly with longer lifespan in yeast and worms (Yang
and Sauve, 2005). In yeast, Sir2 plays a critical role in transcriptional silencing and in genomic
stability (Lamming et al., 2004; Denu, 2005). The key question is whether sirtuins regulate healthier
aging in mammals.
Seven Sir2 homologs (SIRT1-7) have been identified in mammals (Porcu and Chiarugi, 2005;
Pallas et al., 2008). Mammalian sirtuins have diverse locations and multiple targets, and affect
a broad range of cellular processes (Supplementary Figure 1). SIRT1 is the human homolog of
sir2 and appears to be involved in several physiological functions including the control of gene
Braidy et al. Sirtuins in the aging rat brain
expression, cell cycle regulation, apoptosis, DNA repair,
metabolism, and aging (Anastasiou and Krek, 2006; Qin et al.,
2006; Smith and Denu, 2006). SIRT1 is localized in the nucleus
and can deacetylate numerous proteins such as tumor suppressor
protein (p53), Ku70, NF-κB, and forkhead proteins which
modulate genes that control cellular stress resistance (Smith,
2002). The deacetylase activity of specific sirtuin proteins
is dependent on the intracellular NAD+ content (Sauve et al.,
2006). They catalyze a unique reaction that releases nicotinamide,
acetyl ADP-ribose (AADPR), and the deacetylated substrate
(Sauve et al., 2006). It has been shown that increased SIRT1
activity in human cells can delay apoptosis and rescue vulnerable
cells with additional time to repair after repeated exposure to
oxidative stress (Howitz et al., 2003).
Mammalian SIRT2 is predominantly a cytoplasmic protein
(North et al., 2003). It can deacetylate several cytoskeletal
proteins, including α-tubulin, histones, and forkhead proteins,
although the physiological effect of deacetylation of these
proteins by SIRT2 remains unknown (Choudhuri et al., 2003;
North et al., 2003; Brunet et al., 2004; van der Horst et al.,
2004). SIRT2 protein expression levels also appear to increase
during the mitotic phase of the cell cycle, and overexpression can
delay mitosis (Dryden et al., 2003). Consistent with the idea that
SIRT2 can protect against neurodegenerative pathology in mouse
models of Alzheimer’s disease, overactivation of SIRT2 has been
shown to protect against axonopathy and neurodegeneration in a
mouse model ofWallerian degeneration (Arraki et al., 2004; Tang
and Chua, 2008). Small-molecule inhibitors targeting SIRT2 have
been shown to attenuate several models of neurodegeneration
in vivo (Choudhuri et al., 2003; North et al., 2003; Brunet et al.,
2004; van der Horst et al., 2004). Therefore, it is of significant
interest to determine the anatomical and functional changes of
SIRT2 in the brain during aging.
Mitochondria represent the primary site for the production
of reactive oxygen species (ROS) through one-electron carriers
in the respiratory chain (Beal, 1995). This dynamic organelle
is highly vulnerable to the cytotoxic effect of oxidative stress,
as evidenced by extensive lipid peroxidation, protein oxidation
and mitochondrial DNA (mtDNA) mutations (Beal, 1995,
2007; Mawrin et al., 2003; Andersen, 2004). Experimental
evidence of respiratory chain defects (Braidy et al., 2011) are
in accordance with the mitochondrial theory of aging. The
role of the mitochondrial SIRT3-5 is of great interest with
regard to mammalian aging and age-related brain disorders. Do
mammalian sirtuins regulate metabolism and the oxidative stress
response in the brain during aging? Recently, Ozden et al. (2011)
showed that SIRT3 responds to changes in mitochondrial redox
status by altering the enzymatic activity of specific downstream
targets, including manganese superoxide dismutase (MnSOD).
MnSOD is the primary mitochondrial ROS scavenging enzyme
which modulates ROS levels as well as metabolic homeostatic
poise (Ozden et al., 2011). However, no study to our knowledge
has examined SIRT3-5 mRNA and protein expression levels over
a mammalian aging time course.
SIRT6, is another nuclear specific protein, is a histone H3-
lysine 9 (H3K9) deacetylase, that is necessary to promote
longevity (Liszt et al., 2005; Mostoslavsky et al., 2006; Koltai
et al., 2010). SIRT6 knockout mice display premature aging
symptoms, including excessive loss of subcutaneous fat and a
significant reduction in bone density, and die within 4 weeks of
birth (Mostoslavsky et al., 2006). These animals also demonstrate
impaired DNA base excision repair (BER) and several metabolic
phenotypes (Mostoslavsky et al., 2006). However, the mechanism
by which SIRT6 regulates BER remains unknown. It is interesting
to know whether metabolic changes during aging are associated
with SIRT6.
The least characterized of the sirtuins, SIRT7, is localized in
the nucleolus of mammalian cells. Ford et al. (2006) showed
that SIRT7 protein expression levels correlated with tissue
proliferation and its expression is reduced in non-proliferating
tissue, such as the heart, brain and muscle (Ford et al., 2006).
Recently, SIRT7 has been associated with cellular growth and
metabolism (Ford et al., 2006). In particular, SIRT7 has been
associated with rDNA and interacts with RNA polymerase I
(Pol I), suggesting a role in NAD-dependent regulation (Ford
et al., 2006). Interestingly, both SIRT7, an inducer of rRNA
transcription, and SIRT1, an inhibitor of p53, share similar
features that exhibit a pro-survival role in cells.
Owing to the importance ofmammalian sirtuins in physiology
and aging, we hypothesized that they may be differentially
expressed in the rat brain and may regulate various targets
involved in metabolic processes and neurodegenerative diseases.
To date, very little is known about the anatomical distribution
of these sirtuins throughout the brain or changes which may
occur during aging. Using real-time RT-PCR and western blot
analysis, we have quantified changes in SIRT1-7 mRNA and
protein expression levels in the brains of female wistar rats
aged from 3 to 24 months, spanning life stages from young
adulthood to old age (Coleman, 1989). We also sought to
examine the functional role of sirtuin expression/activity by
assaying superoxide and fatty acid oxidation levels as well as
known targets of sirtuin deacetylation activity, including p53,
FOXO3a, MnSOD, CPS-1, histone H3K9, and polymerase-I.
The implications of these findings for the aging process are
discussed within the context of key sirtuin-related metabolic
processes.
Materials and Methods
Animals
Female wistar rats were used in the following age groups: 3
months (equivalent to a young human adult aged 20 years), 12
months (equivalent to a middle-aged human aged 40 years) and
24 months (equivalent to an aged human greater than 80 years)
(Collier and Coleman, 1991).The animals were individually
housed in an environmentally controlled room under a 12 h
alternating light/dark cycle at 23◦C and were fed commercial rat
chow and water ad libitum. All experiments were performed with
the approval of the Animal Ethics Committee of the University
of Sydney. Anesthesia was induced with a mixture of O2, NO2,
and 5% halothane, followed by an intraperitoneal injection of
sodium pentobarbitone (60mg/kg), and perfused transcardially
as previously described (Chan-Ling, 1997; Mansour et al., 2008).
Whole brain was removed, washed with phosphate buffered
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saline solution (Invitrogen) and used immediately for a variety
of biochemical and histochemical procedures.
RT-PCR for SIRT1-7 mRNA Expression
For the gene expression studies, RNA was extracted from the
frontal, temporal, and occipital lobes and hippocampus, using
Qiagen RNAeasy mini kits (Hilden, Germany). Quantitative and
qualitative analysis of RNA samples was performed using a
2100 Bioanalyzer (Agilent Technologies) to ensure they were of
sufficient quality to generate reliable data (RIN 10). The cDNA
was prepared using the SuperScript III First-Strand Synthesis
System and random hexamers (Life Technologies, Carlsbad,
CA). Gene expression was determined using real-time PCR as
described previously (Lee et al., 2010). Briefly, for each reaction,
2µL of diluted cDNA, 10µL of SYBR green master mix, 0.15µL
of 10µM forward and reverse primers and 7.7µL of nuclease-
free water was used, making a total volume of 20µL. Q-PCR was
carried out using the StratageneMx3500P Real-Time PCR system
(Sydney, Australia). The relative expression levels of SIRT1-
7 were calculated using a mathematical model based on the
individual Q-PCR primer efficiencies and the quantified values
were normalized against the housekeeping gene Glyceraldehyde
Phosphate Dehydrogenase (GAPDH) (Lee et al., 2010). The
primer sequences are shown in Supplementary Table 1.
Western Blots for Assaying Protein Expression of
SIRT1-7, Total/Acetylated p53, MnSOD and
FOXO3
The frontal, temporal, occipital lobes and hippocampus were
carefully dissected from the whole brain and homogenized in
RIPA lysis buffer containing 50mM Tris-HCl (pH 7.4); Igepal
1% (w/v); 0.25% (w/v) Na-deoxycholate; 1mM EDTA, 150mM
NaCl; 1µg/ml each of protease inhibitors aprotinin, leupeptin
and pepstatin; 1mM Na3VO4; and 1mM NaF. After 1 h, the
homogenate was centrifuged (14,000 g, 30min, 40176◦C) and
the supernatant transferred to a clean polypropylene tube. Equal
amounts of protein extract (30µg) were dissolved in Laemmli
sample buffer (Bio-Rad Laboratories, Hercules, CA) and heated
to denature the protein (5min, 95◦C), and loaded onto the
gel in order to execute protein separation. Electrophoresis (160
volts, 50min) was performed using Tris-glycine precast 8–
12% (v/v) gradient polyacrylamide SDS-PAGE gels (Bio-Rad
Laboratories, Hercules, CA) under reducing conditions. Proteins
were transferred onto polyvinylidene difluoride membrane
(0.45µm) (Invitrogen, CA, USA) using Tris/glycine buffer, pH
8.3 (25mM Tris base, 192mM glycine, 0.1% w/v SDS, 20% v/v
methanol) at 140mA for 3 h. Membranes were blocked with
5% (w/v) non-fat milk powder dissolved in Tris-buffered saline
(TBS) for 1 h and incubated with primary antibody overnight at
4◦C. The primary antibodies used are detailed in Supplementary
Table 2. Membranes were then washed in TBS-Tween-20 and
incubated with HRP conjugated secondary antibodies from
Sigma (Castle Hill, Australia) for 1 h at ambient temperature.
After further washing in TBS-Tween-20, the membranes were
incubated with an ECL plus reagent (RPN2132, Amersham)
and protein bands visualized on X-ray films. The bands were
quantified by integration of pixel intensity using ImageJ software
(U.S. National Institutes of Health, Bethesda, Maryland), and
normalized to β-actin, which served as an internal control.
Isolation and Extraction of Nuclei for SIRT1
Deacetylase Activity Assays
Aliquots of brain homogenate from the frontal, temporal,
occipital lobes and hippocampus (extracted without protease
inhibitors) were centrifuged through 4ml of 30% sucrose
solution containing 10mM Tris HCl (pH 7.4); 10mM NaCl; and
3mM MgCl2 (1300 g, 10min, 4
◦C). The remaining pellets were
washed with cold 10mM Tris-HCl (pH 7.4) and 10mM NaCl.
The nuclei were then suspended in 50–100µl extraction buffer
containing 50mM Hepes KOH (pH 7.4); 420mM NaCl; 0.5mM
EDTA; 0.1mM EGTA; and glycerol 10%, sonicated for 30 s, and
allowed to incubate on ice (30min) followed by centrifugation
(10,000 g, 10min). The nuclear extract was immediately stored
at−80◦C for later application of SIRT1 deacetylase activity assay.
SIRT1 Deacetylase Activity
SIRT1 deacetylase activity was evaluated in nuclear extracts
from the frontal, temporal, occipital lobes and hippocampus of
young, middle-aged, and aged rats, using the Cyclex SIRT1/Sir2
Deacetylase Flourometric Assay Kit (Nagano, Japan). The final
reaction mixture (100µl) contained 50mM Tris-HCl (pH 8.8),
4mM MgCl2, 0.5mM DTT, 0.25 mU/ml Lysyl endopeptidase,
1µMTrichostatin A, 200µMNAD+, and 5µl of nuclear sample.
The samples were mixed well and incubated for 10min at room
temperature and the fluorescence intensity (ex. 340 nm, em.
460 nm) was measured at 30 s intervals for a total of 60min
immediately after the addition of fluorosubstrate peptide (20µM
final concentration) using Fluostar Optima Fluorometer (NY,
NY) and normalized to the total protein content. The results are
reported as relative fluorescence/µg of total protein (AU).
Measurement of Superoxide
Assay of superoxide was performed using the lucigenin-enhanced
chemiluminescence assay as previously described (Brown et al.,
2006). Briefly, brain homogenates from the frontal, temporal,
occipital lobes and hippocampus were placed in a polypropylene
tube containing 0.5ml PBS and lucigenin (5µmol/L). The tube
was placed in a Promega GloMax luminometer (Madison, WI) to
detect the relative light units emitted. Background counts were
determined from tissue-free preparations, and the luminescence
subtracted from the brain sample readings.
Manganese Superoxide Dismutase (MnSOD)
Activity
MnSOD activity was measured as previously described (Spitz
and Oberley, 1989). The enzymatic activity of MnSOD was
determined based on the competition between MnSOD and
an indicator molecule for the generation of superoxide from
xanthine and xanthine oxidase, in the presence of 5mM NaCN,
an inhibitor of CuZnSOD activity.
Fatty Acid Oxidation
Fatty acid oxidation was measured as previously described
(Nasrin et al., 2010). Briefly, brain homogenates from the frontal,
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temporal, occipital lobes and hippocampus were incubated in
serum-free media containing 0.5mg/ml bovine serum albumin
and [3H] palmitate (10µM cold palmitate and 8.93µCi/ml
[3H] palmitate) for 90min. Afterwards, 100µl of homogenate
mixture was transferred to a 96-well filter plate containing 100µl
of phosphate-buffered activated charcoal slurry. The plate was
centrifuged (2800 g, 45min, 25◦C), the charcoal-containing plate
was discarded and the filtrate was counted using a Beckman
LS6500 scintillation counter (Beckman-Coultier, Brae, CA).
Bradford Protein Assay for the Quantification of
Total Protein
SIRT1 activity, superoxide levels, MnSOD activity, and fatty
acid oxidation were adjusted for variations in total protein
concentration using the Bradford protein assay (Bradford, 1976).
Data Analysis
Results obtained are presented as the means± the standard error
of measurement (Koch et al., 2006) of at least eight animals per
age group analyzed in duplicate. One-Way analysis of variance
(ANOVA) and post-hoc Tukey’s multiple comparison tests were
used to determine statistical significance between treatment
groups. Differences between treatment groups were considered
significant if p < 0.05.
Results
Regional Changes in Sirtuin mRNA and Protein
Expression in the Aging Rat Brain
We performed RT-PCR andWestern blotting analysis to examine
changes in sirtuin mRNA expression in various regions of the
brain from young, middle-age and aged animals. We observed
a significant increase in SIRT1 mRNA expression in the frontal,
temporal, occipital lobes and hippocampus with age (Table 1,
Supplementary Figure 2), consist with an increase in SIRT1
protein expression in these regions (Table 2). Interestingly,
SIRT2 mRNA (Table 1, Supplementary Figure 1) and protein
expression (Table 2) levels increased only in the occipital lobe,
with no significant increase observed in the other brain regions.
SIRT3-5 mRNA and protein expression declined significantly in
the hippocampus and frontal lobe (Tables 1, 2, Supplementary
Figure 2). In contrast to the increase in SIRT1 expression, our
data also shows that SIRT6 mRNA levels declined significantly
with age, consistent with reduced SIRT6 protein expression in
the same brain regions (Tables 1, 2, Supplementary Figure 2).
As well, SIRT7 mRNA (Table 1, Supplementary Figure 2) and
protein (Table 2) expression was increased only in the frontal
lobe with aging.
SIRT1 Deacetylase Activity but Not Protein
Expression Declines with Aging
SIRT1, an NAD+ dependent deacetylase is primarily localized in
the nucleus (Sauve et al., 2006). Therefore, we assessed the activity
of SIRT1 in nuclear extracts from selected regions of the brain in
aging rats. By 12 months a significant decline in SIRT1 activity
in all brain regions was observed with the greatest decline again
occurring between middle (12 month) and older age (24 months) TA
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FIGURE 1 | Altered SIRT1 activity in the aging rat brain. Reduced SIRT1
activity was observed in the aging rat brain after 12 months of age using a
fluorimetry based assay which detected the deacetylation of lysine residues.
All values are means ± S.E.M. using brains from eight rats for each age group.
Significance *p < 0.01 compared to 3 month old rats.
(Figure 1). In contrast a significant (p < 0.01) increase in the
level of SIRT1 protein was observed in all brain regions examined
using western blotting (Table 2, Supplementary Figure 3).
To investigate the potential downstream effects of altered
SIRT1 activity on the acetylation status of the tumor suppressor
protein p53, we measured both acetylated and total p53 protein
levels using western blotting. As shown in Figure 2, we found a
significant age-dependent increase in acetylated p53 expression
in all brain regions tested. However, no change was observed in
total p53 protein content between young and aged rats in any
brain region.
SIRT2 Can Regulate FOXO3 Expression
Since SIRT2 can deacetylate FOXO3 (Brunet et al., 2004),
we set forth to determine the effect of aging of SIRT2 on
FOXO3 expression. Our data demonstrates that increased SIRT2
expression in occipital lobe (Tables 1, 2, Supplementary Figure
4) is consistent with reduced acetylated FOXO3 expression
(Figure 3). No change was observed in FOXO3 expression in the
frontal, temporal lobes and the hippocampus, in line with the
SIRT2 data.
Altered Superoxide Levels, MnSOD Protein
Expression and MnSOD Activity
Our data indicate a significant decline in MnSOD expression and
enzymatic activity with age in the hippocampus and frontal lobe
(Figures 4A–E), consistent with a reduction in SIRT3 expression
(Tables 1, 2, Supplementary Figure 5). To further confirm the
effects of aging on MnSOD, we measured superoxide levels as
a function of MnSOD activity, since MnSOD can catabolize
superoxide. Superoxide levels significantly increased with age
in the hippocampus and frontal lobe (Figure 4F). In contrast,
measurements of superoxide in the temporal and occipital lobes
were not significantly different than in young rats (Figure 4F).
Changes in Fatty Acid Oxidation
Nasrin et al. (2010) showed that SIRT4 regulates fatty acid
oxidation and mitochondrial gene expression. To determine
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FIGURE 2 | Reduced SIRT1 activity promotes p53 acetylation in the
aging brain. Acetylated p53 and total p53 levels were determined by
Western blotting in (A) frontal lobe, (B) temporal lobe, (C) occipital lobe, and
(D) hippocampus in the brain with aging using anti-acetylated p53 and
anti-total p53 antibodies. The blots shown are representative tracings of an
experiment repeated eight times. Graphs are mean ± S.E brains of data from
brains using eight rats for each age group. Significance *p < 0.01 was
established by comparison with 3 month old rats.
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FIGURE 3 | FOXO3 protein expression is altered in the aging rat brain
occipital lobe. Western blotting for FOXO3 in (A) frontal lobe, (B) temporal
lobe, (C) occipital lobe, and (D) hippocampus in the brain with aging using
anti-FOXO3a antibody. The blots shown are representative tracings of an
experiment done eight times. Graphs are mean ± S.E brains from brains
from eight different rats for each age group. Each bar of the quantification
graph represents the corresponding band for each age group. Significance
*p < 0.01 compared to 3 month old rats.
whether altered SIRT4 expression can affect metabolic function
in the aging rat brain, we measured fatty acid oxidation
as a target of SIRT4 activity in various brain regions.
Fatty acid oxidation significantly increased with age in the
hippocampus and frontal lobe (Figure 5) consistent with a
decrease in SIRT4 expression (Tables 1, 2, Supplementary Figure
6). The amount of fatty acid oxidation and SIRT4 expression
did not change significantly in the temporal and occipital
lobes.
Increased Acetylated CPS1 Correlates with
Reduced SIRT5 Expression in the Hippocampus
and Frontal Lobe
Nakagawa et al. (2009) recently showed that carbamoyl
phosphate synthetase 1 (CPS1) is a SIRT5-binding protein.
Consistent with this finding, we observed increased levels of
acetylated CPS1 in the hippocampus and frontal lobe of the
aging rat brain (Figure 6) in conjunction with decreased SIRT5
expression in these brain regions (Tables 1, 2, Supplementary
Figure 7). Acetylated CPS1 levels in the temporal and occipital
lobes remained unchanged, in line with observed pattern for
SIRT5 expression.
SIRT6 May Regulate Histone Acetylation in the
Aging Rat Brain
To explore a potential functional effect of increased SIRT6
expression in the aging brain, we measured H3K9 histone
acetylation. We observed a significant increase in H3K9
acetylation in various brain regions (Figure 7) consistent with
an age-dependent decline in SIRT6 expression (Tables 1, 2,
Supplementary Figure 8), parallel to an increase in SIRT1
expression (Tables 1, 2, Supplementary Figure 2).
SIRT7 Can Influence Protein Transcription via
Regulation of RNA Polymerase-I
Since SIRT7 can interact with Pol I (Ford et al., 2006), we tested
the age-related effect of SIRT7 on Pol I expression. Our data
shows that Pol I expression increases with age only in the frontal
lobe (Figure 8), consistent with the observed increase in SIRT7
expression (Tables 1, 2, Supplementary Figure 9).
Discussion
Sirtuins are key NAD-dependent class III histone deacetylase
enzymes that have been extensively investigated to determine
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FIGURE 4 | Reduced MnSOD correlates with SIRT3 pattern of
expression in the aging rat brain. Western blotting for MnSOD in
(A) frontal lobe, (B) temporal lobe, (C) occipital lobe, and (D)
hippocampus in the brain with aging using anti-MnSOD antibody. The
blots shown are representative tracings of an experiment done eight
times. Graphs are mean ± S.E brains from brains from eight different
rats for each age group. Each bar of the quantification graph
represents the corresponding band for each age group. Significance
*p < 0.01 compared to 3 month old rats. (E) MnSOD activity in aged
rat brain tissue. Significance *p < 0.01 compared to 3 month old rats.
(F) Superoxide levels in aged rat brain tissue. Significance *p < 0.01
compared to 3 month old rats.
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their role in various disease conditions (Chen et al., 2005;
Denu, 2005, 2007; Anastasiou and Krek, 2006; Anekonda and
Reddy, 2006; Belenky et al., 2007; Chen and Guarente, 2007;
Dali-Youcef et al., 2007). Numerous studies have highlighted
the myriad of intrinsic and extrinsic biological effects, which
FIGURE 5 | SIRT4 protein expression regulates fatty oxidation in the
aging rat brain. Fatty acid oxidation in aged rat brain tissue. Significance
*p < 0.01 compared to 3 month old rats.
play important neuroprotective roles in neurodegenerative and
cerebrovascular conditions, including stroke, ischaemic brain
injury, Alzheimer’s disease, Parkinson’s disease, Huntington’s
disease and amyotrophic lateral sclerosis (Longo and Kennedy,
2006; Gan, 2007; Okawara et al., 2007; Milne and Denu, 2008;
Pallas et al., 2008). However, to date, very little has been reported
regarding mammalian sirtuin distribution and functional role in
the central nervous system and to our knowledge this is the first
study examining sirtuin expression and functional changes with
aging.
SIRT1, the human ortholog of Sir2α, is localized
predominantly in the nucleus of neurons, and regulates
several important physiological processes such a chromatin
remodeling, gene transcription, and the activity of several
apoptotic mediators, particularly p53 (Pillai et al., 2005; Sauve
et al., 2006). Indeed, increased SIRT1 activity by mediators
of caloric restriction, such as resveratrol have been shown to
prolong lifespan by a number of different processes, including
reduced apoptosis and improved DNA repair (Arraki et al.,
2004; Borra et al., 2005; Raval et al., 2006; Qin et al., 2006).
SIRT1 expression has been previously shown to progressively
increase with age in both young and older endothelial cells.
Although a significant increase in SIRT1 expression was reported
FIGURE 6 | Raised acetylated CPS1 protein levels in the aging rat
brain. Western blotting for acetylated CPS1 in (A) frontal lobe, (B) temporal
lobe, (C) occipital lobe, and (D) hippocampus in the brain with aging. The
blots shown are representative tracings of an experiment done eight times.
Graphs are mean ± S.E brains from brains from eight different rats for each
age group. Each bar of the quantification graph represents the
corresponding band for each age group. Significance *p < 0.01 compared to
3 month old rats.
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FIGURE 7 | Raised acetylated H3K9 protein levels in the aging rat
brain. Western blotting for acetylated H3K9 in (A) frontal lobe, (B) temporal
lobe, (C) occipital lobe, and (D) hippocampus in the brain with aging. The
blots shown are representative tracings of an experiment done eight times.
Graphs are mean ± S.E brains from brains from eight different rats for each
age group. Each bar of the quantification graph represents the
corresponding band for each age group. Significance *p < 0.01 compared to
3 month old rats.
in young cell, a significant decline in SIRT1 was observed in
older cells (Conti et al., 2015). This suggests that the SIRT1
pathway is more effective in younger cells. Oxidative stress may
lead to a reduction in SIRT1 and its regulatory control on target
proteins, thus promoting cellular senescence. Moreover, SIRT1
has been proposed to play a major role in neuroprotection. While
several studies have demonstrated the protective roles of sirtuin
activators during aging, little is known regarding the distribution
or activity of SIRT1 in the aging brain.
We have shown that aging is associated with increases in
SIRT1 expression level, but decreases in the activity of SIRT1
in nuclear extracts from selected brain regions. The decreased
activity of SIRT1 in the aging rat brain is consistent with the
observed decrease in substrate (NAD+) level that is observed
during aging (Braidy et al., 2011). Oxidative damage may also
potentially inhibit SIRT1 activity, as it does to several other
proteins (Radak et al., 2009). The current observations are
consistent with a previous study which reported decreased SIRT1
activity but not expression in skeletal muscle of aged rats (Koltai
et al., 2010). It is also likely that the age-associated drop in NAD+
content due to increased demand by the DNA repair process may
induce a compensatory increase in SIRT1 production to enhance
its competitive advantage for the available NAD+ (Koltai et al.,
2010). Exercise training has been shown to slow down the aging
process by increasing SIRT1 activity, modulating an antioxidant
response and mediating cell cycle regulation in aged rats (Ferrara
et al., 2008).
On the contrary to previous studies, Gong et al. (2014)
recently showed that SIRT1 expression is reduced with age at the
transcriptional and translational levels in the brain, liver, skeletal
muscle, and white adipose tissue in senescence-accelerated
mouse prone (SAM-P8) and a control counterpart strain,
senescence-accelerated mouse resistant 1 (SAM-R1). Moreover
SIRT1 expression levels were significantly lower in SAM-P8
compared to SAM-R1 mice (Gong et al., 2014). We postulate that
SAM series may exhibit differential genetic backgrounds apart
from the accelerated senescence-related ones which may alter
both the expression and function of sirtuins (Ito, 2013).
The neuroprotective effects of SIRT1 are thought to be
mediated in part by the deacetylation and hence inhibition of
p53. We therefore measured the expression of both total and
acetylated p53 in aging brain tissue. Our results show a significant
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FIGURE 8 | Raised Pol I protein levels in the aging rat brain.
Western blotting for Pol I in (A) frontal lobe, (B) temporal lobe, (C)
occipital lobe, and (D) hippocampus in the brain with aging. The blots
shown are representative tracings of an experiment done eight times.
Graphs are mean ± S.E brains from brains from eight different rats for
each age group. Each bar of the quantification graph represents the
corresponding band for each age group. Significance *p < 0.01 compared
to 3 month old rats.
increase in acetylated p53 protein while no change was observed
in total p53 protein content. This is consistent with work done
by others showing that cells derived from SIRT1-deficient mice
had elevated levels of acetylated p53 (Ford et al., 2005), and that
sirtuin inhibition leads to hyperacetylated p53 (Yamakuchi et al.,
2008). These results suggest that age-related changes in SIRT1
activity can regulate the post-translational acetylation of p53
(Pillai et al., 2005). Increased SIRT1 activity has been previously
shown to represses p53 activity to prevent p53-dependent
cellular senescence. It is therefore likely that our observation
of concurrently decreased SIRT1 activity and increased p53
expression level are causally linked. Our present study provides
supporting evidence for an age related change in the brain SIRT1-
p53 axis that is consistent across at least four cortical regions.
These age related changes to SIRT1 activity, and in turn p53
expression, may be driven by availability and changes in brain
levels of NAD+, which are known to decrease during aging
(Braidy et al., 2011). Ramadori et al. (2008) recently showed
that reduced energy availability can lead to lower levels of
acetylated p53 only in the hypothalamus and hindbrain within
the normal brain, and the effect is altered in leptin-deficient
obese mice (Ramadori et al., 2008). Level of NAD+ may therefore
be central to regulation of a variety downstream effects on
senescence regulating proteins; however, further work is needed
to investigate these relationships.
SIRT2 has been shown to promote longevity in yeast,
nematodes and fruitflies, although the life-span promoting effect
has not been observed in humans (Lamming et al., 2004). In
human cells, SIRT2 has been shown to mediate cell survival
through mitotic control (Dryden et al., 2003). SIRT2 regulates
microtubule dynamics by deacetylating several cytoskeletal
proteins including tubulin, and regulates cell cycle progression
(North et al., 2003). Overexpression of SIRT2 has been reported
to lengthen mitosis, and reduced expression of SIRT2 has an
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antiapoptotic effect (Dryden et al., 2003; North et al., 2003).
Compared to the other sirtuins, SIRT2 expression has been found
to be greatest in the brain (Pandithage et al., 2008). Although
SIRT2 is mainly found in oligodendrocytes, and myelin-forming
glial cells (Pandithage et al., 2008), SIRT2 has been recently
described in the cytoplasm of hippocampal neurons in the adult
mouse brain (Li et al., 2007). There is argument for (Werner
et al., 2007) and against the localization of SIRT2 in astrocytes
(Li et al., 2007), the second major brain glial cell type. However,
other studies have shown that SIRT2 is present in both neurons
and astrocytes (Michan and Sinclair, 2007; Werner et al., 2007;
Pandithage et al., 2008; Ramadori et al., 2008).
To investigate the effect of SIRT2 function during aging, we
examined the levels of FOXO3 protein levels in the aging brain.
Our study shows that both SIRT2 and FOXO3 undergo age
related expression changes only in the occipital lobe, and that
in this case their expression levels are inversely related. The
FOXO transcription factors are regulated by post-translational
modifications, and SIRT2-mediated deacetylation of FOXO3 can
influence FOXO3 ubiquitination and degradation (Wang et al.,
2011). Brunet et al. (2004) showed that SIRT2 deacetylation of
FOXO protein can activate a myriad of genes that may regulate
cell survival, thus shifting vulnerable cells from apoptosis toward
growth arrest and DNA repair (Brunet et al., 2004). However, the
significance of the upregulated SIRT2 in the occipital lobe with
aging cannot be easily interpreted in the light of brain aging.
The biological significance of its upregulation in the occipital
lobe with aging, in all of its cellular locales, is not immediately
apparent, but its cellular distribution supports currently known
roles.
We and others have previously shown that increased ROS
formation and reduced mitochondrial efficiency may contribute
to impaired physiological function, increased incidence of
disease, and a reduction in life span (Beal, 1995, 2003, 2007;
Budd and Nicholls, 1996; La Piana et al., 1998; Budd et al.,
2000; Gibson et al., 2000; Menzies et al., 2002a,b; Jacquard et al.,
2006; Ahn et al., 2008; Braidy et al., 2011). Therefore, it is
highly likely that acetylation ofmitochondrial proteinsmay play a
critical role in regulating mitochondrial ROS levels (Ozden et al.,
2011). SIRT3 is the main mitochondrial deacetylase (Shi et al.,
2005; Ahn et al., 2008), and SIRT3 knockout studies have shown
an increase in ROS, including the levels of the highly reactive
superoxide anion both in vitro and in vivo (Lombard et al., 2007).
Therefore, SIRT3 appears to represent a regulatory molecule
that maintains mitochondrial homeostasis by mediating the
acetylation of metabolic target protein, including those that form
part of the endogenous antioxidant defense system. This is the
first study to show that brain SIRT3 expression levels decline
with age and in parallel with lower MnSOD protein levels,
MNSOD activity, and increased superoxide (O2.
−) levels in the
rat hippocampus and frontal lobe. This is relevant to Alzheimer’s
disease where the hallmarks of the disease (i.e., senile plaques
and neurofibrillary tangles) are predominantly observed in the
hippocampus and frontal lobe of the brain (Alafuzoff et al., 1987).
MnSOD is the primary mitochondrial antioxidant enzyme
which neutralizes O2.
− to the less reactive hydrogen peroxide
(H2O2) followed by conversion to H2O by catalase in the
mitochondrial matrix (Oberley and Oberley, 1988). Superoxide
is a byproduct of normal oxidative phosphorylation and ATP
production and can lead to extensive damage to lipids, proteins
and DNA (Henderson et al., 2009). Since MnSOD enzymatically
scavenges superoxide, whose levels are significantly increased in
SIRT3-deficient cells (Spitz and Oberley, 1989), it seems likely
that an age-related reduction in SIRT3 expression may lead to
reduced MnSOD activity and thereby higher oxidative damage
and altered redox signaling. Tao et al. (2010) recently showed
that SIRT3-mediated deacetylation of Lysine 122 can regulate
MnSOD activity in response to stress (Tao et al., 2010). While
the current data does not indicate a definite relationship between
SIRT3-mediated acetylation of MnSOD during pathological
processes, it is highly likely that SIRT3 may play a protective role
against ROS by regulating the enzymatic properties of MnSOD
during aging and particularly in chronic age-induced oxidative
stress.
SIRT4 is another mitochondrial sirtuin that may be altered
in the brain during the aging process. Recently, SIRT4 has been
shown to inactivate glutamate dehydrogenase, an enzyme which
converts glutamate to α-ketoglutarate in the mitochondria in an
NAD+ dependent manner (Haigis et al., 2006). Although the
function of SIRT4 remains unclear, we speculated that SIRT4
might be involved inmitochondrial oxidativemetabolism. Nasrin
et al. (2010) recently showed that SIRT4 regulates fatty acid
oxidation and mitochondrial gene expression in liver and muscle
cells. SIRT4 knockdown in hepatocytes also increased SIRT1
mRNA protein levels both in vitro and in vivo, suggesting that the
effect of SIRT4 on fatty acid oxidation may be SIRT1 dependent
(Nasrin et al., 2010). Here, we show a significant increase in fatty
acid oxidation in the aging rat brain in the hippocampus and
frontal lobe which is closely associated with a reduction in SIRT4
expression. How SIRT4 regulates fatty acid oxidation with aging
is unknown, but could be related to changes in NAD+/NADH
and/or AMP/ATP ratios. Another possibility is the role of
SIRT4 in modulating AMPK-SIRT1 pathways (Nasrin et al.,
2010). Activation of AMPK increases NAD+ levels which can
increase SIRT1-mediated deacetylation of LκB1 which increases
acetyl-CoA carboxylase (ACC) phosphorylation, leading to
increased fatty acid oxidation (Nasrin et al., 2010). Alternatively,
it is possible that SIRT1 increases as a compensatory effect to
replace SIRT4 function in SIRT4-knockout mice (Nasrin et al.,
2010). Therefore, sirtuins may represent a synergistic network
which regulates metabolic signals and mitochondrial function
during aging.
While SIRT3 and SIRT4 appear to directly modulate the
activity of mitochondrial enzymes associated with energy
metabolism, little is known regarding the cellular role of SIRT5.
Our data is the first to show an age related reduction in SIRT5
expression in the hippocampus and frontal lobe, consistent with
the expression changes of the other two mitochondrial sirtuins,
SIRT3 and SIRT4. Our data support the findings by Nakagawa
et al. (2009) who showed that SIRT5 could deacetylate CPS1
in a NAD-dependent manner and this deacetylation increased
CPS1 enzymatic activity (Nakagawa et al., 2009). Indeed, SIRT5
knockout mice have ∼30% reduction in CPS1 activity compared
to wild type mice. During fasting conditions, calorie restriction
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or following consumption of a high protein diet, SIRT5 deficient
mice failed to up-regulate CPS1 activity resulting in hyper
ammonemia (Nakagawa et al., 2009). Taken together, these data
indicate that SIRT5 has an emerging role in themetabolic changes
that take place during aging.
Like SIRT1, SIRT6 is another chromatin-associated nuclear
protein that has been shown to affect DNA repair, telomere
maintenance, gene expression, and metabolism (Mostoslavsky
et al., 2006). We have shown that SIRT6 expression declines with
age in the frontal, temporal, occipital lobes and hippocampus
in the aging rat brain. SIRT6 deficient mice have a significantly
reduced lifespan and suffer from severe multisystemic
phenotypes (Mostoslavsky et al., 2006). SIRT6 can deacetylate
histone H3K9, a chromatin marker that is associated with
longevity (Schwer et al., 2010). Histone acetylation is relevant
to several neurodegenerative diseases including schizophrenia,
depression, addiction, and various neurodevelopment disorders
(Schwer et al., 2010). However, the mechanism by which SIRT6
can regulate histone acetylation in the brain during aging remains
obscure. We analyzed H3K9 acetylation in several brain regions.
Our data indicates a significant increase in H3K9 acetylation
in various brain regions consistent with an age-dependent
decline in SIRT6 expression, and occurs parallel to an increase
in SIRT1 expression. Loss of SIRT6 has been shown to induce
dramatic H3K9 hyperacetylation in the hypothalamus, cortex,
hippocampus and cerebellum, and in purified brain nuclei.
Similarly, increased acetylation of H3K9 has been reported
in SIRT6 deficient mice, while the acetylation levels of other
histones remained unaffected (Schwer et al., 2010). Together,
these results suggest that SIRT6 is the main H3K9 deacetylase in
the brain, suggesting a potential role in gene regulation with age.
We also investigated the role of SIRT7 in the aging rat brain.
Our data shows that SIRT7 is upregulated in the frontal lobe
with aging. Ford et al. (2006) showed that SIRT7 can interact
with Polymerase-I (Pol I) (Ford et al., 2006). As transcription
of rDNA by Pol I accounts for 65% of total transcription in
mammalian cells, Pol I appears to be highly coordinated with
cellular metabolism and cellular proliferation (Grummt, 2003).
We found that Pol I expression increases with age only in
the frontal lobe, consist with the observed increase in SIRT7
expression. In yeast, Sinclair and Guarente (1997) showed that
Sir2 can mediate longevity, primarily through its silencing role at
the rDNA (Sinclair and Guarente, 1997).Therefore, maintenance
of cellular energy status may be coupled with levels of RNA
synthesis, protein transcription, and therefore cell growth, which
is dysregulated during the aging process.
Sirtuins represent a unique class of enzymes that not only
regulate protein acetylation and metabolism, but also play
prominent roles in promoting longevity, preventing disease
and improving cell survival. Our present study describes
the anatomical landscape of mammalian sirtuins and their
downstream targets within the brain (Supplementary Figure
10). On the contrary to our finding, a recent study showed
that no significant decreases in the expression of any sirtuin
member were observed in any brain region between the 24
month old and 3 month old Wistar rats. As well, the mRNA
expression patterns for specific sirtuins were never parallel to
its corresponding translational expression pattern in that study
(Sidorova-Darmos et al., 2014). However, the cellular biology
of altered sirtuin expression in various brain regions remains
unknown. It is unclear which cells in the brain contain sirtuins.
Previous studies have suggested that only specific neuronal
brain cells may express functional sirtuin protein (Hasahara
et al., 2005; Sidorova-Darmos et al., 2014). Sidorova-Darmos
et al. (2014) further examined the expression patterns of
sirtuins in murine brain cells. While SIRT2 mRNA was largely
expressed in both neurons and astrocytes, SIRT2 protein was
expressed in astrocytes only. Similarly, SIRT5 was expressed
at the translational level in neurons, although its mRNA was
also identified in both astrocytes and neurons (Sidorova-Darmos
et al., 2014). If this hypothesis is correct, then only certain
cells may be responsible for the age-related effects in the
brain. Additionally, the effects of calorie restriction on sirtuin
activity in specific brain regions and certain brain cells have
not been investigated. The fact that all mitochondrial sirtuins
are expressed in brain neurons is important with respect to
their protective roles against neurodegenerationTaken together,
our results provide additional evidence for the role of sirtuins
in regulating brain function at different stages of development.
It also identifies the potential for pharmacologically targeting
specific sirtuins to establish cell-specific effects within the brain.
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